Apellis Announces Craig Wheeler to Join the Board of Directors
April 23, 2025
Apellis Pharmaceuticals, Inc. (APLS) has announced the immediate appointment of Craig Wheeler to its Board of Directors. Wheeler, the founder and CEO of Headwaters Biotech